Sponsors
Blog
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Research & Development
Utilising cutting-edge water-based nanotechnology
By Ayelet Dilion-Mashiah, Do-Coop Technologies Ltd. Bringing a new drug to market is one of the most expensive procedures in the business world. As the costs of new drug development currently weigh in at approximately $500 million, late-stage failure is a disaster for the company’s finances.
Highest productivity in drug discovery experiments
Multiplexed technologies increase productivity, if two conditions are met: there is no room for tedious manual labor and derived data offers additional content. Anagnostics' technology, based on a cylindrical microarray, processes up to 96 assays fully automated in a single device. The system's unique capability of kinetic scans is applied to on/off rate measurements or activity determinations of enzymes.
Like a bridge over troubled waters: Neowater closes R&D gaps for the pharma and biotech industry
Bringing a new drug to market is one of the riskiest ventures in the business world. Ms. Ayelet Dilion-Mashiah, VP Business Development at Do-Coop Technologies, explains how Neowater is propelling pharma and biotech development past some of the field's most frustrating obstacles to full market viability.
Cyclobenzaprine ER: partnering for success in lifecycle management
By Eurand. Patients’ unmet needs due to inconvenient dosing and significant side effects with existing therapies led to the collaboration to develop Amrix®, the first and only once-daily skeletal muscle relaxant available in the U.S.
The engineering challenge of synthetic biology
By Genostar Bioinformatics Solutions. Bioinformatics and computational modeling are essential to meeting the challenges and developing the potential of synthetic biology. A new generation of computer-aided design tools for validation of synthetic networks is rapidly emerging.
Source: www.ngpharma.eu.com© 2012 GDS Publishing Ltd. All rights reserved.